Pacific Surgical Specialties is set to raise capital using MFP’s new and revolutionary SFS program

Medical Funding Professionals (MPF) is pleased to announce that Pacific Surgical Specialties – Distribution, Inc. has engaged MFP to implement the Capital Planning Valuation Strategy™ in preparation for the company’s Regulation A+ offering through MFP’s recently launched Secured Financed Services™ (SFS) program.

Pacific Surgical Specialties is an innovative medical device company focusing on bipolar electrodes for urology surgical procedures. The company’s extensive range of electrodes are designed for optimized cutting efficiency, cutting quality, and unmatched durability and reliability, resulting in the new gold standard in electrode tip configurations across all major resectoscope platforms.

The company can offer a cost savings of 20-40% over its competition to help improve the profitability of bipolar procedures for its customers. The company’s electrodes are designed to work with all common applicators and instruments, making them a trusted device for use in operating rooms across the US. The company’s electrodes have gained rapid adoption by Urologists, IDNs, Surgery Centers, and GPOs.

“We provide the highest quality at the best price for a wide range of electrodes while maintaining surgeon preference. And because we focus exclusively on Urology, we can rapidly provide physicians with incremental innovations to help them continuously improve patient outcomes.” -Yancy W. Riddle, PhD - COO.

Seeking funds for market expansion, Pacific Surgical Specialties is set to undergo its first offering of securities via Regulation A+, a JOBS-Act exemption which allows private companies to raise up to $75 million per year online from accredited and non-accredited investors. Pacific Surgical Specialties has engaged a full team of industry professionals under the SFS™ program to manage the front-end buildout for the raise, including registered investment advisors like Medical Funding Professionals, corporate legal counsel, and financial modeling and communications. 

The SFS program allows Pacific Surgical Specialties to finance the up-front cost of services required to build a company-branded online capital fundraising platform for their upcoming offering. SFS works like other traditional and alternative financing strategies, requiring limited cash out-of-pocket on the full suite of professional services required to launch the offering with the remaining costs paid over time.

“MFP has put together a seamless service that covers everything that a growing medtech company would want in relation to raising capital in today’s investment environment,” continues Dr. Riddle. Their SFS program is what makes this all possible – without it we’d struggle to fund the cost of building and launching our offering. MFP offers a best-in-class strategy to formulate and capitalize a company for the present and future.”

“We are thrilled to be working with Pacific Surgical Specialties,”

says Medical Funding Professionals CEO Stephen Brock. “They have a breakthrough technology that is transforming how urology procedures are performed, and it’s our mission to help them introduce this valuable technology to the world.”

About Pacific Surgical Specialties

Pacific Surgical Specialties was created with one major goal in mind: to perfect bipolar electrodes and to offer these ideal styles across all platforms of power and instrumentation. The result is the Pacific Surgical Specialties collection of bipolar electrodes. The bipolar electrodes were developed based on feedback from physicians and clinical supply chain professionals. The company’s complete line of high-quality bipolar electrodes is FDA 510k approved, which means the FDA has determined the devices are safe and effective for use. Pacific Surgical Specialties fine-tuned the design of bipolar electrodes with the intent to enhance performance, reduce cost, and ensure consistent quality. With an outstanding track record of physician adoption and great value, Pacific Surgical Specialties is enjoying rapid adoption in hospitals and surgery centers across the USA. Pacific Surgical Specialties is also gaining significant traction with group purchasing organizations whose function it is to find and deliver the best clinical and financial value to their customers.

About Medical Funding Professionals

Medical Funding Professionals (MFP) is a registered investment advisory located in Nevada. MFP provides funding solutions for short- and long-term startups as well as mid-market private and public companies in the biotech, medtech, life sciences, and pharmaceuticals industries through Reg A+, Reg CF, and Reg D 506(c) funding as well as government grants and other non-dilutive funding sources such as cooperative agreements and other non-traditional government-backed strategies. MFP has 22 years of experience in the capital markets with over a decade securing funding for medical and life sciences companies. MFP’s in-depth knowledge of capital raising rules and regulations, including Reg A+, Reg CF, Reg D, OTC markets, reverse mergers, NASDAQ, FINRA, SEC, and Sarbanes Oxley Act Compliance, has proven invaluable in helping clients navigate the complex fundraising process and raise capital efficiently.

About Secured Financed Services™ (SFS)

SFS™ is an invitation only, capital planning, secured project finance model derived from a combination of financing strategies available to the best-of-the-best pharma, biotech, and life sciences companies with solid management teams. 

SFS has three key pillars:

1. Defer up to 53% of the fixed costs to build a company-branded online capital raising platform at a time when the need for cash is most critical.

2. Cost-effectively raise capital concurrently from sophisticated investors and a broader more diverse pool of investors – namely investment dollars from retail investors.

3. Settle accounts over 12 to 18 months.

“Beginning in the mid-90s, everyone raced to build a website to market and sell goods and services, now with the JOBS Act , the play is taking those websites to the next level and building company branded platforms to market and sell their stock, notes, bonds and other securities, but they need a cost-effective strategy to do that – SFS,” says Medical Funding Professionals CEO Stephen Brock.

Regulation A+ Disclaimer

This communication may be deemed to be a solicitation of interest under Regulation A under the Securities Act of 1933, in which case the following apply:

• No money or other consideration is being solicited, and if sent in response, will not be accepted;

• No offer to buy the securities can be accepted and no part of the purchase price can be received until the offering statement is qualified, and any such offer may be withdrawn or revoked, without obligation or commitment of any kind, at any time before notice of its acceptance given after the qualification date;

• A person’s indication of interest involves no obligation or commitment of any kind; and 

• An offering statement, which would include a preliminary offering circular, has not yet been filed with the SEC.

If you’d like to learn more about our new and revolutionary SFS model and how we can help you achieve your capital raising goals for your medtech, pharma, biotech, or life science company, you can schedule a time with me here by clicking on this link "Schedule A SFS Call" and choosing a specific date and time that works for you.

Contact

Stephen Brock, CEO

• Phone: (775) 772-3684

• Email: [email protected]

• Website: www.medicalfundingpro.com

Disclaimer: